ArticleCureus2025
Paroxysmal Nocturnal Hemoglobinuria-Driven Hepatic Vein Thrombosis: A Case of Budd-Chiari Syndrome in Disguise.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired hematopoietic stem cell disorder characterized by complement-mediated intravascular hemolysis and a markedly increased risk of thrombosis, including at atypical splanchnic sites. We report a 26-year-old woman who presented with progressive abdominal distension, right upper quadrant pain, early satiety, and morning dark-colored urine. Investigations revealed normocytic anemia, biochemical evidence of intravascular hemolysis, moderate ascites, hepatomegaly, and elevated D-dimer; direct and indirect antiglobulin tests were negative. Flow cytometry using FLAER (Fluorescent AERolysin) and CD55/CD59 confirmed large PNH clones in granulocytes and monocytes, consistent with classic PNH complicated by hepatic vein thrombosis, Budd-Chiari syndrome (BCS). She received therapeutic anticoagulation and complement inhibition with eculizumab, alongside supportive transfusions and monitoring, with progressive clinical and laboratory improvement. This case emphasizes that BCS may be the presenting manifestation of PNH in young patients without conventional thrombotic risk factors and highlights the importance of prompt flow cytometry testing and initiation of complement inhibition to reduce morbidity and recurrence of thrombotic events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.